• Adipose-Neural Axis Drives Arrhythmia via Leptin-NPY Pathway

  2026-06-25

  Fan et al. (2024) demonstrate that the interplay between epicardial adipose tissue and the sympathetic nervous system, mediated by the leptin–NPY–Y1R axis, is a key driver of cardiac arrhythmias. Their innovative human stem cell-based coculture model provides new molecular targets and an advanced experimental platform for mechanistic arrhythmia research.

• Lypressin Acetate: Bridging Antidiuretic and Antiviral Innov

  2026-06-25

  Explore how Lypressin acetate advances both antidiuretic research and antiviral assay development. This article delivers a unique, mechanistic perspective on lysine vasopressin acetate, with actionable protocols and cross-domain insights.

• Dacarbazine: Applied Workflows and Troubleshooting in Oncolo

  2026-06-24

  Dacarbazine is a cornerstone antineoplastic chemotherapy drug for malignant melanoma, Hodgkin lymphoma, and sarcoma models. This guide delivers actionable protocols, troubleshooting strategies, and evidence-driven workflow enhancements—empowering cancer researchers to maximize experimental reproducibility and interpret DNA damage assays with confidence.

• Staurosporine in Metastasis Modeling: Unveiling Apoptosis-Dr

  2026-06-23

  Explore how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, uniquely enables advanced modeling of apoptosis-induced metastasis in cancer research. This article reveals mechanistic links between kinase inhibition, cell death, and pro-metastatic state induction—extending beyond standard apoptosis assays.

• Nanoparticle-Mediated mRNA Reverses Trastuzumab Resistance i

  2026-06-23

  This study introduces a tumor microenvironment-responsive nanoparticle system for systemic delivery of PTEN mRNA, targeting the PI3K/Akt pathway to overcome trastuzumab resistance in HER2-positive breast cancer. The findings highlight a promising approach for restoring tumor suppressor function and improving monoclonal antibody therapy outcomes.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-06-22

  This study demonstrates that tumor microenvironment-responsive nanoparticles can systemically deliver PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN and inhibiting PI3K/Akt signaling, the approach offers a promising precision strategy for resistant cancer phenotypes.

• Ribonuclease R (20 U/μL): Streamlining Circular RNA Enrichme

  2026-06-22

  Ribonuclease R (RNase R) (20 U/μL) from APExBIO transforms circular RNA research by delivering highly selective linear RNA digestion, critical for advanced RNA structure-function and inflammation studies. Explore optimized workflows, troubleshooting strategies, and the translational impact of RNase R in dissecting complex RNA-mediated pathways.

• Synthetic Modified mRNA Enables Rapid hiPSC-to-Oligodendrocy

  2026-06-21

  The referenced study demonstrates a non-viral, synthetic modified mRNA (smRNA) approach for efficiently differentiating human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes. By using OLIG2 S147A smRNA, the protocol achieves high-purity oligodendrocyte progenitor cells in six days, offering a safer and faster alternative to traditional methods for cell therapy and disease modeling.

• DFCP1 Modulates Starvation-Driven Lipid Droplet Lipolysis vi

  2026-06-20

  The reference study identifies DFCP1 as a nutrient-sensitive regulator of lipid droplet metabolism, acting through direct modulation of ATGL-mediated lipolysis during starvation. These insights clarify key molecular mechanisms in lipid mobilization and have implications for metabolic disease research and advanced protein stability workflows.

• Sodium Ascorbate: From Molecular Mechanism to Oncology Model

  2026-06-19

  Explore the advanced mechanistic role of sodium ascorbate, a mineral salt of ascorbic acid, in precise oncology research. This in-depth analysis reveals how nuanced ROS modulation and necrotic tumor cell death inform the next generation of glioblastoma and immunotherapy modeling.

• SIRT1-Regulated Ran Lactylation Drives Astrocyte Polarizatio

  2026-06-19

  This study uncovers a novel mechanism in which lactate-induced lactylation of the small GTPase Ran at lysine 123, regulated by SIRT1, enables astrocyte polarization following oxygen-glucose deprivation/reoxygenation (OGD/R). These findings highlight the importance of non-histone protein lactylation in central nervous system injury repair, offering new molecular targets for therapeutic intervention.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Applied Rese

  2026-06-18

  Kanamycin Sulfate empowers researchers with a reliable, water-soluble antibiotic for precision selection and mechanistic studies in antibiotic resistance and RNA therapeutics. This guide details optimized workflows, protocol parameters, and troubleshooting strategies that elevate experimental success across microbiology and molecular biology domains.

• Mechanistic Precision in Protein Extraction for Translationa

  2026-06-18

  A deep dive into the mechanistic underpinnings of the MAPK10/KRT16 axis in NSCLC metastasis and the strategic value of advanced plant cell lysis workflows for translational researchers. This article bridges high-fidelity protein sample preparation with the frontiers of molecular oncology, offering protocol insights and competitive guidance for maximizing downstream assay reliability—anchored in the unique capabilities of APExBIO’s Plant Cell Lysis Buffer for WB and IP.

• EZ Cap EGFP mRNA 5-moUTP: Optimizing mRNA Delivery & Imaging

  2026-06-17

  EZ Cap™ EGFP mRNA (5-moUTP) empowers researchers to achieve robust, immune-silent fluorescence expression for gene regulation, cell viability, and in vivo imaging studies. This guide translates recent machine learning-driven delivery insights and real-world workflow strategies into actionable protocols and troubleshooting tips.

• Metabolic Intervention Enhances Ferroptosis and Cuproptosis

  2026-06-17

  This study introduces a nanosystem that synchronously sensitizes tumor cells to both ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. The dual activation not only promotes regulated cell death but also remodels the tumor immune microenvironment, pointing to new strategies for advanced cancer therapies.

11457 records 1/764 page Next 12345 下5页 Last page